Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,210 total articles
Sportradar has deepened its multi-year partnership with Hard Rock Bet in the U.S. by integrating official PGA TOUR and Ultimate Fighting Championship data, enhancing in-play betting capabilities and offering dynamic micro markets and advanced visualizations to users. This expansion leverages Sportradar’s recent acquisition of IMG ARENA rights for P…
Tonix Pharmaceuticals has dosed the first participant in a Phase 1 study evaluating TNX-1900, an intranasal potentiated oxytocin formulation, in healthy volunteers to assess its potential for treating migraine and craniofacial pain by inhibiting CGRP release through a novel pathway. The study uses advanced Laser Speckle Contrast Imaging (LSCI) to m…
Hyperion DeFi, Inc., the first U.S. publicly listed DeFi company on Hyperliquid, announced robust financial results for Q4 and FY 2025. The company exceeded Q4 guidance with 64% revenue growth and 87% growth in adjusted gross profit quarter-over-quarter. It operates five diversified DeFi business lines, including staking, validator commissions, yie…
Ligand Pharmaceuticals has expanded its business development team by hiring two seasoned healthcare investors, Peter Renehan, MD and Lee Brown, and promoting Lauren Hay to Vice President of Portfolio Strategy and Investments. These hires aim to enhance Ligand's ability to source and execute royalty financing opportunities, supporting long-term valu…
Tilray Brands has announced a new licensing agreement with The Magnum Ice Cream Company to produce and distribute ready-to-drink Popsicle Hard beverages, featuring classic Popsicle flavors with 5% alcohol by volume. The product line, including Hard Cherry, Hard Orange, Hard Grape, and a seasonal Hard Firecracker flavor, targets the US adult beverag…
Lifecore Biomedical announced two new contract development and manufacturing organization (CDMO) agreements with an existing U.S.-based biopharmaceutical customer. The agreements include a site transfer for manufacturing a currently marketed product and expansion of manufacturing to a second delivery system for an ophthalmic treatment. These deals …
WeShop Holdings Limited, a US-listed social commerce platform, announced the launch of its Founders Programme in the UK. The initiative aims to empower early community creators by offering them increased referral rewards, exclusive events, and direct engagement opportunities to help grow the platform. This move is part of WeShop's strategy to accel…
Agomab Therapeutics announced that the USPTO granted a composition of matter patent for AGMB-447, its inhaled lung-restricted ALK5 inhibitor in development for idiopathic pulmonary fibrosis (IPF). This patent protection extends in the U.S. through at least 2041, supporting the company's clinical-stage pipeline targeting fibrosis. AGMB-447 is curren…
Kamada Ltd., a global biopharmaceutical leader in specialty plasma-derived therapies, announced FDA approval of its new plasma collection center in San Antonio, Texas. The facility can collect up to 50,000 liters of plasma annually, with expected revenues of $8-10 million at full capacity. This center will enhance Kamada's plasma collection capabil…
Cibus, Inc., an agricultural technology company specializing in gene-edited plant traits, has priced a public offering of nearly 7 million Class A shares at $2.15 each, aiming to raise approximately $15 million before expenses. The proceeds will be used for working capital and to advance development of weed management traits in rice. The offering i…
TransUnion announced the release date for its first quarter 2026 financial results on April 28, 2026. The company will publish a press release at 6:00 a.m. CT followed by a conference call at 8:30 a.m. CT to discuss its earnings. TransUnion is a global information and insights company specializing in credit data, fraud prevention, marketing, risk, …
KANZHUN LIMITED, trading as BOSS Zhipin on Nasdaq, announced ongoing execution of its share repurchase program, spending approximately RMB34.4 million to buy back 748,460 ordinary shares on March 25, bringing total repurchases in 2026 to over RMB480 million. This action reflects the company's commitment to enhance shareholder value.
Comstock Inc. announces its 2026 Annual Meeting of Shareholders to be held on May 28, 2026, in Reno, Nevada. The meeting will cover topics including Comstock Metals, strategic investments, and clean energy systems. The company emphasizes its focus on innovating technologies to recycle metals from end-of-life photovoltaics. The notice includes detai…
22nd Century Group, a Nasdaq-listed company specializing in reduced nicotine tobacco products, reported fourth quarter and full year 2025 results showing strategic progress in expanding its proprietary VLN® low nicotine cigarette product across more retail outlets and states, elimination of $8 million legacy debt, and a strong year-end cash positio…
Abercrombie & Fitch's brand Hollister teams up with singer-songwriter Gigi Perez to release a reimagined version of Green Day's 'Good Riddance (Time of Your Life)' as part of a graduation season campaign. The initiative includes an original music video featuring young creatives and a new product collection themed around milestone moments, aimed at …
GRAVITY Co., Ltd. announced the official launch of Ragnarok Origin Classic, a multi-platform MMORPG available on PC and mobile devices, in Korea, Taiwan, Hong Kong, Macau, and Southeast Asia on March 26, 2026. The game features a monthly pass system and revamped combat design to enhance player engagement by focusing on skill and strategy, aiming to…
Lumexa Imaging announced robust preliminary financial results for Q4 and full year 2025, highlighted by revenue growth, improved adjusted EBITDA and margin expansion driven by advanced imaging volumes, new center openings, and key payer network returns. The company also reiterated its full-year 2026 guidance with expectations of continued growth an…
Pony AI Inc. announced a substantial 160% year-over-year increase in Robotaxi revenues and a 500%+ surge in fare-charging revenues in Q4 2025. The company's fleet surpassed 1,400 units with expansions in China and overseas cities such as Croatia and Qatar. Achieving unit economics breakeven in multiple Tier-1 Chinese cities and launching mass produ…
Olaplex Holdings, a leading science-driven prestige hair care company listed on NASDAQ as OLPX, announced a definitive agreement for acquisition by Henkel AG & Co. KGaA for $2.06 per share in cash, valuing Olaplex at approximately $1.4 billion, representing a 55% premium over the closing share price. The transaction, expected to close in the second…
Brookfield Wealth Solutions Ltd. announced the filing of its 2025 annual report and audited financial statements for the year ended December 31, 2025, with both the SEC and Canadian securities authorities. The filings are publicly accessible online and hard copies are available to shareholders on request.
Archrock, a Houston-based energy infrastructure company specializing in midstream natural gas compression, announced that CFO Douglas S. Aron plans to retire by the end of 2026 or upon appointment of a successor. The company has engaged an executive search firm to find a replacement. The leadership affirmed confidence in the company's strategy and …
Ascentage Pharma reported a 90% year-over-year increase in product sales and commercial rights revenues for 2025, driven by significant growth in sales of Olverembatinib and the launch of Lisaftoclax in China. The company is advancing multiple ongoing global registrational Phase III clinical trials, including several FDA and EMA cleared studies, wh…
ArrowMark Financial Corp. announced its estimated and unaudited Net Asset Value (NAV) as of February 28, 2026, at $21.18 per share. The firm is a closed-end fund listed on NASDAQ focusing on income through investments primarily in regulatory capital securities of financial institutions. The announcement includes a reminder of associated investment …
Oragenics, Inc., a clinical-stage biotech company focused on brain-targeted therapeutics via intranasal delivery, announced it received an unqualified audit opinion containing a going concern explanatory paragraph for its 2025 financial statements. This indicates substantial doubt about its ability to continue as a going concern, reflecting financi…
XORTX Therapeutics Inc. disclosed a 1-for-5 share consolidation effective March 27, 2026, approved by its board and regulatory bodies, aimed at ensuring compliance with NASDAQ's $1.00 minimum bid price requirement. The company's total outstanding shares will decrease from approximately 6.96 million to 1.39 million, adjusting convertible securities …
